Popescu I - Search Results

1

Challenges in anti-aging medicine-trends in biomarker discovery and therapeutic interventions for a healthy lifespan.

Popescu I, Deelen J, Illario M, Adams J. Popescu I, et al. J Cell Mol Med. 2023 Sep;27(18):2643-2650. doi: 10.1111/jcmm.17912. Epub 2023 Aug 23. J Cell Mol Med. 2023. PMID: 37610311 Free PMC article. Review.

2

Insulin for "hearts that had lost hope" - on the first pediatric patients and the 1923 Nobel Prize in Physiology or Medicine.

Popescu I. Popescu I. J Pediatr Endocrinol Metab. 2024 Jan 12;37(3):193-196. doi: 10.1515/jpem-2023-0560. Print 2024 Mar 25. J Pediatr Endocrinol Metab. 2024. PMID: 38204172 No abstract available.

3

Diabetes pharmacotherapy and effects on the musculoskeletal system.

Kalaitzoglou E, Fowlkes JL, Popescu I, Thrailkill KM. Kalaitzoglou E, et al. Among authors: popescu i. Diabetes Metab Res Rev. 2019 Feb;35(2):e3100. doi: 10.1002/dmrr.3100. Epub 2018 Dec 20. Diabetes Metab Res Rev. 2019. PMID: 30467957 Free PMC article. Review.

4

Postnatal loss of the insulin receptor in osteoprogenitor cells does not impart a metabolic phenotype.

Fowlkes JL, Clay Bunn R, Kalaitzoglou E, Ray P, Popescu I, Thrailkill KM. Fowlkes JL, et al. Among authors: popescu i. Sci Rep. 2020 Jun 1;10(1):8842. doi: 10.1038/s41598-020-65717-3. Sci Rep. 2020. PMID: 32483283 Free PMC article.

5

Genetic ablation of SGLT2 function in mice impairs tissue mineral density but does not affect fracture resistance of bone.

Thrailkill KM, Bunn RC, Uppuganti S, Ray P, Garrett K, Popescu I, Pennings JS, Fowlkes JL, Nyman JS. Thrailkill KM, et al. Among authors: popescu i. Bone. 2020 Apr;133:115254. doi: 10.1016/j.bone.2020.115254. Epub 2020 Jan 25. Bone. 2020. PMID: 31991250 Free PMC article.

6

Advances in micro- and nanotechnologies for the GLP-1-based therapy and imaging of pancreatic beta-cells.

Moonschi FH, Hughes CB, Mussman GM, Fowlkes JL, Richards CI, Popescu I. Moonschi FH, et al. Among authors: popescu i. Acta Diabetol. 2018 May;55(5):405-418. doi: 10.1007/s00592-017-1086-7. Epub 2017 Dec 20. Acta Diabetol. 2018. PMID: 29264724 Review.

7

Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.

Kalaitzoglou E, Popescu I, Bunn RC, Fowlkes JL, Thrailkill KM. Kalaitzoglou E, et al. Among authors: popescu i. Curr Osteoporos Rep. 2016 Dec;14(6):310-319. doi: 10.1007/s11914-016-0329-9. Curr Osteoporos Rep. 2016. PMID: 27704393 Free PMC article. Review.

8

Heterogeneity and altered β-cell identity in the TallyHo model of early-onset type 2 diabetes.

McDonald S, Ray P, Bunn RC, Fowlkes JL, Thrailkill KM, Popescu I. McDonald S, et al. Among authors: popescu i. Acta Histochem. 2022 Oct;124(7):151940. doi: 10.1016/j.acthis.2022.151940. Epub 2022 Aug 12. Acta Histochem. 2022. PMID: 35969910

9

Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits.

Thrailkill KM, Bunn RC, Uppuganti S, Ray P, Popescu I, Kalaitzoglou E, Fowlkes JL, Nyman JS. Thrailkill KM, et al. Among authors: popescu i. Bone. 2020 Dec;141:115625. doi: 10.1016/j.bone.2020.115625. Epub 2020 Sep 2. Bone. 2020. PMID: 32890778 Free PMC article.

10

Impact of an SGLT2-loss of function mutation on renal architecture, histology, and glucose homeostasis.

Hughes CB, Mussman GM, Ray P, Bunn RC, Cornea V, Thrailkill KM, Fowlkes JL, Popescu I. Hughes CB, et al. Among authors: popescu i. Cell Tissue Res. 2021 May;384(2):527-543. doi: 10.1007/s00441-020-03358-8. Epub 2021 Jan 6. Cell Tissue Res. 2021. PMID: 33409652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,049 results

Search Page